MARETTI, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.206
AS - Asia 4.800
EU - Europa 4.353
SA - Sud America 720
Continente sconosciuto - Info sul continente non disponibili 250
AF - Africa 105
OC - Oceania 50
Totale 19.484
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.974
SG - Singapore 1.433
IT - Italia 1.275
CN - Cina 1.154
GB - Regno Unito 1.151
VN - Vietnam 621
BR - Brasile 560
HK - Hong Kong 539
SE - Svezia 496
DE - Germania 311
BD - Bangladesh 235
FR - Francia 216
RU - Federazione Russa 196
FI - Finlandia 173
IN - India 173
KR - Corea 137
UA - Ucraina 125
CA - Canada 123
TR - Turchia 95
ID - Indonesia 70
NL - Olanda 69
BG - Bulgaria 65
JP - Giappone 65
AR - Argentina 64
BE - Belgio 63
MX - Messico 51
PL - Polonia 42
AU - Australia 40
IQ - Iraq 37
PK - Pakistan 31
IR - Iran 28
EC - Ecuador 24
ES - Italia 24
ZA - Sudafrica 24
LT - Lituania 23
AE - Emirati Arabi Uniti 20
IE - Irlanda 20
PH - Filippine 20
CL - Cile 19
CO - Colombia 19
MY - Malesia 17
KE - Kenya 16
TW - Taiwan 16
MA - Marocco 14
JM - Giamaica 13
VE - Venezuela 13
AZ - Azerbaigian 12
UZ - Uzbekistan 12
TH - Thailandia 11
AT - Austria 10
EG - Egitto 10
NP - Nepal 10
NZ - Nuova Zelanda 10
TN - Tunisia 10
CZ - Repubblica Ceca 9
IL - Israele 9
JO - Giordania 9
RS - Serbia 9
CH - Svizzera 8
HU - Ungheria 8
PE - Perù 8
RO - Romania 8
CR - Costa Rica 7
PT - Portogallo 7
PY - Paraguay 7
EE - Estonia 6
GR - Grecia 6
GT - Guatemala 6
KZ - Kazakistan 6
MD - Moldavia 6
SA - Arabia Saudita 6
BB - Barbados 5
BY - Bielorussia 5
DK - Danimarca 5
DZ - Algeria 5
GE - Georgia 5
HN - Honduras 5
EU - Europa 4
HR - Croazia 4
LK - Sri Lanka 4
LV - Lettonia 4
NG - Nigeria 4
SC - Seychelles 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
AL - Albania 3
BO - Bolivia 3
CI - Costa d'Avorio 3
LB - Libano 3
ML - Mali 3
MN - Mongolia 3
PA - Panama 3
PR - Porto Rico 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
BH - Bahrain 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
KG - Kirghizistan 2
Totale 19.206
Salva come PNG Salva come JPEG
Città #
Ashburn 1.099
Singapore 920
Santa Clara 852
Southend 721
Fairfield 571
San Jose 564
Chandler 541
Hong Kong 519
Woodbridge 356
Council Bluffs 329
Nyköping 257
Hefei 249
Beijing 242
Dearborn 241
Houston 235
Ann Arbor 225
Wilmington 218
Modena 210
Jacksonville 208
Ho Chi Minh City 196
Seattle 193
London 179
Cambridge 176
Los Angeles 162
Hanoi 153
New York 131
The Dalles 127
Helsinki 126
Seoul 120
Milan 109
Columbus 68
Princeton 62
Moscow 60
Lauterbourg 58
Sofia 58
San Diego 54
Bremen 53
Buffalo 53
Dallas 52
Redwood City 51
Frankfurt am Main 50
Rome 49
Eugene 48
Chicago 46
Shanghai 45
Fremont 44
São Paulo 42
Tokyo 42
Bologna 40
Izmir 40
Da Nang 38
Brussels 36
Jakarta 36
Ottawa 34
Warsaw 33
Orem 31
Munich 30
Naples 30
Atlanta 29
Phoenix 29
Denver 28
Boardman 26
Chennai 24
Haiphong 24
Montreal 23
Mumbai 23
Parma 23
Formigine 22
Mexico City 22
Porto Alegre 22
Rio de Janeiro 22
Basingstoke 20
San Francisco 20
Amsterdam 19
Sydney 19
Falls Church 18
Guangzhou 18
Toronto 17
Dublin 15
Hangzhou 15
New Delhi 15
Boston 14
Brooklyn 14
Charlotte 14
Johannesburg 14
Belo Horizonte 13
Nanjing 13
Napoli 13
Padua 13
Quito 13
Reggio Nell'emilia 13
Washington 13
Kunming 12
La Puente 12
Lappeenranta 12
Nairobi 12
Nuremberg 12
Baghdad 11
Dhaka 11
Gurgaon 11
Totale 12.245
Salva come PNG Salva come JPEG
Nome #
The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant 423
Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones? 420
Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery 412
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis 401
Characterization of natural clays from italian deposits with focus on elemental composition and exchange estimated by edx analysis: potential pharmaceutical and cosmetic uses 397
pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells 390
Gastroretentive montmorillonite-tetracycline nanoclay for the treatment of Helicobacter pylori infection 387
Organo-modified bentonite for gentamicin topical application: interlayer structure and in vivo skin permeation 377
Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy 369
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 367
Anti-TB inhalation therapy: Design of mannose-based functionalised Solid Lipid Microparticles for an active targeting to alveolar macrophages 354
In vivo silica nanoparticle translocation across human stratum corneum: the effect of surface hydrophobization in relation to hair follicle density. 354
Application of the "in-oil nanoprecipitation" method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 353
In vivo penetration of bare and lipid-coated silica nanoparticles across the human stratum corneum 349
Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes 347
Novel engineered lipid-based nanoparticles for pulmonary tuberculosis inhalation therapy 334
Polymeric and Solid Lipid Nanoparticles for nose-to-brain delivery of geraniolursodeoxycholic acid conjugate: development and characterization studies 332
DEVELOPMENT AND COMPARISON OF TWO LIPID-BASED NANOSYSTEMS FOR THE CO-DELIVERY OF RIFAMPICIN AND ISONIAZID: SMALL-ANGLE NEUTRON SCATTERING CHARACTERISATION 323
Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability 317
pH sensitive PEGylated Liposomes delivering active hydrophilic peptide with anticancer activity: in vitro study on cDDP-resistant ovarian cell line 310
In vitro behaviour of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin 303
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 298
Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia 298
Small-angle neutron scattering characterization of liposomes for anti-tuberculosis inhaled therapy. 296
Nanoencapsulation of an hTS inhibitor octapeptide against ovarian cancer in solid lipid matrix 289
In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment? 286
Development and in vitro characterization of SLN encapsulating magnetic Heparin coated Iron Oxide for theranostic application 278
Self-assembled organogelators as artificial stratum corneum models: key-role parameters for skin permeation prediction 273
SURFACE ENGINEERING OF SOLID LIPID NANOASSEMBLIES FOR INHALED INTRAMACROPHAGIC ANTI-TB THERAPY 272
Inhaled SLM for anti-TB therapy by DPI device: process parameters affecting freeze-drying and breathability 271
Lipid-based microparticles for TB inhaled therapy: physical properties and cell internalization 270
SOLID LIPID MICROPARTICLES FOR INHALED ANTI-TB THERAPY BY DPI: INFLUENCE OF THE PRODUCTION PROCESS ON DRUG STABILITY AND POWDER BREATHABILITY 270
Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation 270
In vitro evaluation on CaCo-2 cells of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin. 269
Aerodynamic performance of lipid-based nanocarrier functionalized by novel mannose derivatives for Rifampicin intramacrophagic delivery 267
Formulazione per veicolare principi attivi lipofili 266
Self-assembling organogelators for artificial stratum corneum models: key-role parameters in skin permeation prediction 262
Tetracycline-Montmorillonite nanoclay for the treatment of H. pylori infection 252
Development of lipid nanocarriers as delivery systems for a small peptide with anti-ovarian activity 249
Chitosan/heparin polyelectrolyte complexes as ion-paring approach to encapsulate heparin in orally administrable SLN: In vitro evaluation 246
Metodo per modulare l'assorbimento fagocitario di un principio attivo o un suo precursore da parte di macrofagi 239
PROGETTAZIONE E OTTIMIZZAZIONE DI SISTEMI MICROPARTICELLARI PER LA VEICOLAZIONE AI MACROFAGI ALVEOLARI DI FARMACI ANTITUBERCOLARI PER VIA INALATORIA 236
Inhalated drug delivery systems to target alveolar macrophages for tuberculosis therapy: design of safe SLM loaded with rifampicin 233
Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease 229
PASSIVE AND ACTIVE TARGETING TO MACROPHAGES USING LIPID NANOPARTICLES ASSEMBLIES FOR ANTI-TB THERAPY BY PULMONARY ROUTE 225
Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy 223
Formulazione per veicolare principi attivi lipofili 221
Medicinal Chemistry drives drug targeted delivery: a successful interplay 211
Nuove molecole funzionalizzanti per il targeting ai macrofagi di vettori lipidici 201
Development of solid lipid nanoparticles for the delivery of an anti- inflammatory drug to muscle skeletal cells 201
In vivo β-carotene skin permeation modulated by Nanostructured Lipid Carriers 200
The improvement of Solid Lipid Microparticle breathability for an anti-TB inhalation therapy 199
Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives 189
Nasal biocompatible powder of geraniol oil complexed with cyclodextrins for neurodegenerative diseases: Physicochemical characterization and in vivo evidences of nose to brain delivery 189
Combination of Nanodelivery Systems and Constituents Derived from Novel Foods: A Comprehensive Review 185
Linking endocannabinoid system, palmitoylethanolamide, and sarcopenia in view of therapeutic implications 183
Inhaled micro- or nanoparticles: which are the best for intramacrophagic anti-infectious therapies? 179
Solid Lipid Microparticles for inhaled anti-TB therapy by DPI: influence of the production process on drug stability and powder breathability 176
Inflammatory-Targeted Lipid Carrier as a New Nanomaterial to Formulate an Inhaled Drug Delivery System 175
Design and physicochemical characterization of novel hybrid SLN-liposome nanocarriers for the smart co-delivery of two antitubercular drugs 170
APPLICATION OF A NEW SURFACTANT FOR INHALED ANTI-INFLAMMATORY DRUG DELIVERY SYSTEMS: FROM NANOCARRIER TO PURE NANODRUG FORMULATION 165
Palmitoylethanolamide-loaded Solid Lipid Nanoparticles for a therapeutic anti-inflammatory approach of Sarcopenia involving ECS 161
Dispositivo per la somministrazione intravaginale di batteri e loro metaboliti 153
Plant Resin Delivery by Nanovectors as an Emerging Approach to Boost Solubility, Permeability and Bioavailability 152
Nanoparticulate systems for the delivery of Palmitoylethanolamide to muscle cells 148
Investigating hybrid lipid-PLGA nanoparticles loaded with an endogenous endocannabinoid-like molecule for targeting inflamed muscle 136
Optimizing Formulation Conditions of PLGA Microparticles to Enhance Indomethacin Encapsulation 130
Inhaled lipid nanoparticles: a feasible tool for a challenging route 124
IMMOBILIZATION OF HEPARIN BY TERNARY POLYELECTROLYTE COMPLEXES: A PRELIMINARY STUDY 111
New insights on Indomethacin and PLGA interaction for a rational design of microparticles to be administered via intra-articular route 111
Lipid Nanodrugs for topical anti-inflammatory treatment of psoriasis: in vivo studies 107
Physicochemical characterization of SLN/Liposomes hybrid nanoparticles for the co-delivery of two antitubercular drugs: focus on SANS analysis 106
Design and development of hybrid plga nanoparticles for the co-delivery of trimetazidine and palmitoylethanolamide for the treatment of sarcopenia 104
Investigating Hybrid PLGA-Lipid Nanoparticles as an Innovative Delivery Tool for Palmitoylethanolamide to Muscle Cells 103
ENGINEERING OF DRUG DELIVERY SYSTEMS TO ENHANCE DRUG POTENTIAL: FROM BEADS TO POLYMER-FREE NANOPARTICLES 99
Nanoparticle-mediated delivery to skeletal muscle cells of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule with anti-inflammatory properties 91
Comparative in vitro study of lipid and polymeric nanoparticles for the delivery of PEA to myoblasts. 91
Development of a Heparin-Loaded Polyelectrolyte Complex for pH-Responsive Wound Healing Applications 83
Polymeric nanoparticles as a favorable delivery system to enhance the anti-inflammatory action of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule 81
Smart nanodelivery of palmitoylethanolamide for topical treatment of inflammatory skin diseases 79
Targeted Nanodrugs for Inhaled Therapy of Inflammatory Lung diseases 64
ENGINEERING A NANO‑OLEOGEL SYSTEM TO ENHANCE ORAL ADMINISTRATION OF PEA FOR ANTI‑INFLAMMATORY APPLICATIONS 49
Anti-inflammatory endocannabinoid-like molecule for topical and pulmonary administration: comparison between two different nano-delivery systems 34
Dual‑loaded nanoparticles targeting inflammation as multimodal strategy against sarcopenia 31
Dual-Modulated Heparin Delivery from Electrospun PVA Nanofibers for Wound Healing: The Role of Polyelectrolyte Complexes and Fiber Crosslinking 28
MULTIFUNCTIONAL HYBRID LIPID-PLGA NANOPARTICLES FOR DUAL DRUG DE-LIVERY: SURFACE FUNCTIONALIZATION WITH M12 PEPTIDE FOR MUSCLE TAR-GETING 24
Device for the intravaginal administration of bacteria and their metabolites 19
In vitro study emulating muscle response to stimuli exploiting 3D tissue model 18
Design of a new drug delivery system for the treatment of skin inflammatory diseases: smart delivery of palmitoylethanolamide 17
Totale 19.484
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.971
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.971
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.079 0 0 0 59 55 123 50 88 180 120 276 128
2022/20231.475 222 205 105 172 162 171 29 143 148 24 59 35
2023/2024863 34 67 69 94 174 106 70 74 18 28 50 79
2024/20253.311 78 30 118 227 601 429 311 249 359 156 342 411
2025/20266.021 389 199 432 559 785 388 914 388 671 644 374 278
2026/20271.933 206 631 755 341 0 0 0 0 0 0 0 0
Totale 19.484